.jpg?#)
Lupin Signs Licensing, Supply And Distribution Deal With Chinese Firm For Obesity Drug
The Mumbai-based drug maker said the agreement strengthens the company's diabetes portfolio and accelerates its presence in the obesity segment.
The Mumbai-based drug maker said the agreement strengthens the company's diabetes portfolio and accelerates its presence in the obesity segment.
What's Your Reaction?
